Article
A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
13 Dec 2021
Abstract excerpt
Abstract The ability to identify robust genomic signatures that predict response to immune checkpoint blockade is restricted by limited sample sizes and ungeneralizable performance across cohorts. To address these challenges, we established Cancer-Immu (http://bioinfo.vanderbilt.edu/database/Cancer-Immu/), a comprehensive platform that integrates large-scale multidimensional omics data, including genetic, bulk,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
